Boston Scientific
905 hedge funds and large institutions have $57.1B invested in Boston Scientific in 2022 Q1 according to their latest regulatory filings, with 107 funds opening new positions, 357 increasing their positions, 289 reducing their positions, and 84 closing their positions.
56% more funds holding in top 10
Funds holding in top 10: 9 → 14 (+5)
27% more first-time investments, than exits
New positions opened: 107 | Existing positions closed: 84
24% more repeat investments, than reductions
Existing positions increased: 357 | Existing positions reduced: 289
2% more funds holding
Funds holding: 890 → 905 (+15)
0.99% less ownership
Funds ownership: 91.29% → 90.31% (-0.99%)
14% less call options, than puts
Call options by funds: $312M | Put options by funds: $361M
15% less capital inflows, than outflows
Capital inflows: $2.89B | Capital outflows: $3.41B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$278M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$233M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$138M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$93.5M |
| 5 |
Bank of New York Mellon
New York
|
+$88.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$628M |
| 2 |
Newport Trust Company
Washington,
District of Columbia
|
-$330M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$268M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$265M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$251M |
BSX Hedge Fund Activity: Q1 2022 in Review
905 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2022, worth a combined $57.1B — up 3.2% from $55.3B a quarter earlier.
Buyers outnumbered sellers: 107 funds opened new BSX positions and 84 closed out — a net gain of 23 holders — while 357 added to existing stakes and 289 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $278M. The largest seller was Janus Henderson Group, cutting an estimated $628M.
- 905 institutional investors held Boston Scientific (BSX) as of Q1 2022, up from 890 in Q4 2021.
- Funds reported $57.1B of Boston Scientific stock for Q1 2022, up 3.2% quarter-over-quarter.
- 107 funds opened new Boston Scientific positions in Q1 2022 and 84 closed out, a net change of +23 holders.
- The largest Boston Scientific buyer in Q1 2022 was Citadel Advisors, an estimated $278M added.
- The largest Boston Scientific seller in Q1 2022 was Janus Henderson Group, an estimated $628M sold.
Based on aggregated 13F filings for Q1 2022.